Ambr 250 High Throughput Bioreactor System

                          Request for Information (RFI)

                     Ambr 250 High Throughput Bioreactor System

General Information:

This is an RFI as defined in FAR 15.201(e) to ascertain whether a commercial item exists that provides the capabilities described herein.   

This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI will be treated as business confidential information.  Nonetheless, submitters should properly mark their responses if the information is confidential.  Responses to the RFI will not be returned.  Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract.  Responders are solely responsible for all expense associated with responding to this RFI.

RFI Response and due date:4 March 2025

Instructions to Responders:

Responses from all capable and qualified sources are encouraged to respond to this request. 

White papers should adhere to the following formatting and outline instructions:

1.   All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF.

2. Cover Page (1page)

• Title
• Organization
• Responders technical and administrative points of contact (names, addresses, phone, fax number and email addresses)
• Topic area(s) addressed
• NAICS Code

3.   Interested parties are asked to respond to this RFI and submit a capabilities statement that supports the focus of this RFI.  Please review the place of performance requirements. Please submit written responses via email in Microsoft Office 2000 or later format.  All responses should be complete: in 12-point font; and not to exceed 3 pages total, including graphics, tables, and appendices.

No hardcopies shall be accepted. No written solicitation document is available at this time. Telephone requests will not be honored, and no bidders list shall be maintained. No inquiries regarding any potential future acquisition activities shall be entertained.

Potential offerors are requested to direct all questions via email to the Point of Contact listed below. Responses are due to the Point of Contact, Brenda Mena at email: brenda.i.mena.civ@health.mil no later than 10:00AM ET, Tuesday 4 March , 2025.

Background/Overview:  This requirement is for a Brand Name or Equivalent

Ambr 250 High Throughput Bioreactor System  and meets the Statement of Work and the Minimum Essential Characteristics (MECs).  The period of performance will be one base year to include delivery, equipment, installation and one year support plus three option periods for support.

All authorized resllers, if offering a Brand Name Ambr 250 High Throughput Bioreactor System, must provide evidence of its agreement with the Original Equipment Manufacturer at time of response.

If response is specific to meeting just the MEC and the Statement of Work, and not the Brand Name  Ambr 250 High Throughput Bioreactor System, responses need to demonstrate how it can meet MEC and SOW.